Research on pain-relieving drugs. Covers new pain-management startups, omega-3 approaches, drug safety, and AI-driven drug discovery.
A study published in the Lancet found that a catheter laser procedure combined with medication is more effective than medication alone in treating severe chest pain. The procedure, known as PTMR, stimulates new blood vessel growth and increases circulation to relieve angina symptoms.
A University of Maryland study found that high cholesterol hinders the effectiveness of aspirin in reducing platelet aggregation and preventing heart attacks. The study showed that 60% of patients with high cholesterol levels above 220mg/dL remained at increased risk despite taking daily aspirin doses.
A survey conducted by Dr. Maria Silveira found that many patients and families in Oregon are unaware of their basic rights regarding end-of-life care. The results suggest a need for healthcare providers to actively educate patients about their options, including refusal of treatment, withdrawal of care, assisted suicide, and euthanasia.
Researchers at UCLA and Cambridge report a breakthrough in pain medicine that delivers painkillers directly to affected areas, eliminating unwanted side effects. A single injection of the new medication can alleviate pain for several days, offering a significant improvement over current treatments.
A University of Pennsylvania study suggests that taking ibuprofen before aspirin can inhibit the cardioprotective benefits gained from a daily aspirin regimen. The study found no competitive interaction between aspirin and Tylenol or Vioxx when taken separately.
Researchers found that 6-beta naltrexol, a metabolite of naltrexone, can reduce alcohol drinking in rats. The study suggests that 6-beta naltrexol is a potential new medication for treating alcohol dependence.
A comprehensive program involving exercise, weight loss, and joint protection principles is necessary for effective osteoarthritis management. Over-the-counter acetaminophen may be the only required medication for mild-to-moderate pain relief.
A study published in JAMA found that patients taking Celebrex had two- to threefold fewer serious gastrointestinal complications compared to those receiving ibuprofen or diclofenac. The medication was also associated with lower incidence of stomach upset, abdominal pain, and nausea.
The European Respiratory Society warns that hundreds of medicines can cause lung diseases, with 310 therapeutic substances identified as having iatrogenic effects. Early withdrawal of these medicines can reduce the risk of damaging sequelae in 70% of cases.
Researchers present innovative solutions for weight management, metal protection, and pharmaceutical advancements. A dietary supplement may help control weight, fat, and diabetes, while a new coating extends the life of metals tenfold. Additionally, a gentler form of aspirin is developed using polymers.
A potentially safer, more potent form of aspirin made from polymers called PolyAspirin could eliminate stomach irritation and other side effects. The polymer-based drug consists of linked aspirin molecules that break down in the intestine, allowing for efficient delivery and reduced side effects.
Researchers found that ibuprofen significantly reduced inflammation and amyloid plaques in an animal model of Alzheimer's disease, which may help prevent the disease. The study suggests that taking anti-inflammatory drugs early on could delay the onset of AD by about a decade.
Researchers found that administering low to moderate doses of kappa-opioids in conjunction with naloxone causes profound, prolonged pain relief in both men and women. This discovery provides a significant alternative to morphine with minimal side effects.
A large randomized clinical trial shows that self-hypnotic relaxation techniques can decrease pain medication use, reduce operating room time, and improve vital signs during surgery. The study's findings suggest that hypnosis can be a safe and effective method for reducing anxiety and pain in patients undergoing invasive procedures.
A new study published in Thorax suggests that daily or weekly use of paracetamol may be associated with an increased risk of asthma. The research found that frequent users of paracetamol were more likely to develop severe asthma and experience rhinitis, highlighting the potential risks of this analgesic.
A clinical trial revealed that regular aspirin was as effective as sibrafiban in preventing blood clots, while high-dose sibrafiban showed increased risk of death and second heart attacks. Aspirin's minimal risks make it a hard-to-beat option.
Despite evidence supporting aspirin's effectiveness in preventing future heart problems, low usage rates were found among patients with coronary artery disease. The study, published in Circulation: Journal of the American Heart Association, highlights the need for optimal use of life-saving medications.
Researchers found that an experimental pain drug, kappa-opioid, provides effective pain relief to female rats, but has no effect on males. The study suggests a fundamental difference in brain responses between genders, which may lead to the development of more effective and non-addictive pain treatments for women.
A new study reveals that sleep disruption is a primary reason older adults with arthritis seek medical care, outweighing other symptoms like reduced mobility. The research suggests addressing sleep issues can be crucial in managing arthritis, particularly for those who may not connect their pain with sleep disruptions.
A study found that top hospitals in the US are falling short in stroke prevention, with 40% of patients not receiving necessary clot-preventing medications. The study, which analyzed data from 961 patients, also showed that certain groups, such as older adults and those with major heart disease, were more likely to receive treatment.
Methylnaltrexone reverses opioid-induced constipation in over 90% of patients, providing relief from debilitating symptoms. The drug is designed to block morphine's effects on gut motility without interfering with pain relief.
Scientists at Duke University Medical Center discovered a biological mechanism in mice that prolongs morphine's painkilling effects by eliminating a protein switch called beta-arrestin 2. This finding may lead to the development of new drugs that enhance morphine's action and reduce side effects.
A groundbreaking mouse study has identified the molecular mechanism behind morphine tolerance, offering new hope for more effective pain management. The research found that genetically engineered mice lacking a key protein exhibited prolonged analgesia and reduced tolerance to morphine.
A six-year randomized study of 5,059 U.S. veterans found that taking one aspirin a day after a heart attack is as effective as combining it with an anti-clotting drug in reducing post-heart attack risk. The study recommends solo aspirin use due to its cost-effectiveness and lack of need for monitoring.
Millions of patients mix prescription medicines with alternative therapies without informing their doctors, raising concerns about herb-drug interactions. Studies have shown that herbs like St. John's wort and ginkgo can be effective in treating depression, anxiety, and memory problems, but may also cause side effects.
A new clinical trial confirms zaleplon's safety and tolerability for the long-term treatment of insomnia, lasting up to 12 months. The medication showed no withdrawal symptoms upon discontinuation, making it a good option for chronic insomnia sufferers.
UCSF researchers discovered that pain elicits analgesia via the brain's reward pathway, releasing opioids and dopamine. This finding provides a new understanding of pain relief and its connection to addiction.
The Interstitial Cystitis Clinical Trials Group is conducting a clinical trial using pentosan polysulfate sodium (ElmironR) and hydroxyzine hydrochloride (AtaraxR) to treat IC. The trial aims to evaluate the effectiveness of these oral drugs in relieving symptoms in patients with IC.
A new study by the NIH/NINDS found that lower doses of aspirin (81-325mg) taken before and after carotid endarterectomy surgery are more effective in preventing strokes than higher doses. The results suggest that lower doses may be better tolerated and easier to take, making them a promising option for stroke prevention.
A study of over 1,000 older, disabled women reveals that nearly two-thirds report significant pain in multiple areas, yet many use inadequate or ineffective doses of medication. This mismatch suggests a need for better pain management strategies among older adults.
Research found that relaxation and music reduce pain more than pain medication alone, providing complete relief without side effects. These self-care methods can hasten recovery and improve hospital stays for millions of Americans who undergo surgery annually.
The Emory-led WASID study aims to compare the effectiveness of warfarin and aspirin in preventing stroke and vascular death in patients with intracranial stenosis. The five-year trial will evaluate 806 high-risk patients at 50 sites across North America.
Research suggests tart cherries' anthocyanins can prevent oxidative damage and inhibit inflammatory enzymes, rivaling commercial antioxidants like vitamin E. Daily consumption of 20 tart cherries may provide anti-inflammatory benefits for pain relief from arthritis and gout.
A recent study found gabapentin to be at least as effective as tricyclic antidepressants in treating postherpetic neuralgia, with better-tolerated side effects. The eight-week clinical trial involved 229 patients and reported a significant drop in pain levels for those treated with gabapentin.
Researchers are testing a new painkiller to see if it can delay or prevent Alzheimer's disease. The study, involving 1,300 patients, targets the cycloxygenase-2 enzyme, which is believed to contribute to the development of the disease.
Researchers at UT Southwestern Medical Center have discovered how aspirin reduces inflammation by targeting a specific kinase. Aspirin inhibition prevents NF-kB activation and suppresses inflammation, making it an excellent target for developing novel anti-inflammatory agents.
Scientists found that aspirin suppresses accumulation of genetic mutations causing hereditary colorectal cancer. Aspirin screens for cells with stable genetics, potentially preventing the disease. Researchers now plan a clinical trial to study higher doses of aspirin in preventing hereditary colon cancer.
A University of Michigan study found that busy individuals are more prone to medication errors, whereas older adults tend to exhibit better adherence rates. The researchers developed the 'Busy Life Style Questionnaire' to measure daily chaos and identified being too busy as the primary risk factor for mistakes.
A study published in The Journal of Biological Chemistry found that aspirin can short-circuit the
Researchers at Georgia Tech have developed microneedle arrays that can deliver small quantities of high-potency medications through the skin without causing pain. The arrays, produced with microelectronics industry techniques, penetrate only the outermost layer of skin with no nerve endings.
Case reports reveal four patients died or went into shock after switching from mibefradil to other calcium channel blockers, highlighting the dangerous interaction between the two drugs. The risk is attributed to mibefradil's long half-life and its ability to inhibit liver enzymes that metabolize other medications.
A new study found that daily pain among elderly nursing home residents with cancer is widespread and often untreated, especially among older and minority patients. The study highlights inadequate medical treatment and a need for improving pain management in these individuals.
Researchers found that aspirin targets patients with the altered gene PlA2 polymorphism, making them 10 times more sensitive to its effect. This discovery could help determine which people benefit most from daily aspirin doses and when other non-aspirin drugs are needed.
A new study found that low-risk atrial fibrillation patients who take aspirin have a lower risk of stroke compared to those on warfarin, with fewer bleeding complications. The study identified hundreds of thousands of Americans eligible for aspirin therapy and provides new insights into stroke prevention.
Researchers at the University of Pennsylvania School of Medicine found that delivering pain medication to patients before surgery reduces post-operative pain long after. The study, which involved 90 men undergoing radical prostatectomies, showed significant pain reduction in patients who received preemptive analgesia.
Researchers found no benefit from low-dose aspirin therapy in preventing preeclampsia in women at high risk, contradicting previous studies. High blood pressure and protein in urine can lead to eclampsia, which may be fatal.
A recent study at Penn State's Hershey Medical Center found that hospitalized cardiac patients experience significant fluctuations in adjusting to their medications. Researchers discovered that more than 50% of patients went home with at least 10 different medications, creating challenges for managing drug reactions and side effects.
Researchers monitored 60 migraine patients using transcranial Doppler ultrasound before and after six months of treatment. The study found that two-thirds of patients reported clinical improvement, with changes in blood vessel velocity supporting the findings.
Researchers at White River Junction Veterans Administration Medical Center and Dartmouth Medical School have found that more than one protein plays a major role in making acetaminophen toxic to the liver of rats administered alcohol. The study identified CYP3A as another culprit that may cause even more liver damage in individuals who ...
The implant is a button-sized polymer that releases hydromorphone over one to three months, providing steady pain medication. It could be used in developing nations where cancer rates are high but limited treatment options exist, and potentially as an alternative to oral methadone treatment for heroin addicts.
Methylnaltrexone, a medication that blocks morphine side effects without affecting pain relief, has been granted orphan-drug status. This designation will help bring the drug to patients with cancer pain who struggle with nausea and constipation due to long-term opioid use.